The clinical significance of CXCL16 in the treatment of advanced non‐small cell lung cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical significance of CXCL16 in the treatment of advanced non‐small cell lung cancer
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 11, Issue 5, Pages 1258-1264
Publisher
Wiley
Online
2020-03-12
DOI
10.1111/1759-7714.13387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer
- (2015) Elin Richardsen et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
- (2015) Sigurd M. Hald et al. BMC CANCER
- CXCL16 induces angiogenesis in autocrine signaling pathway involving hypoxia-inducible factor 1α in human umbilical vein endothelial cells
- (2015) XIAOWEN YU et al. ONCOLOGY REPORTS
- CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
- (2012) Q. Gao et al. CANCER RESEARCH
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract P2-16-04: Plasma Biomarker Analyses in the AVADO Phase III Randomized Study of First-Line Bevacizumab + Docetaxel in Patients with Human Epidermal Growth Factor Receptor (HER) 2-Negative Metastatic Breast Cancer:
- (2011) DW Miles et al. CANCER RESEARCH
- 804 ORAL Evaluation of Plasma VEGFA as a Potential Predictive Pan-tumour Biomarker for Bevacizumab
- (2011) G.C. Jayson et al. EUROPEAN JOURNAL OF CANCER
- Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors
- (2010) Li Chen et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Expression and regulation of the chemokine CXCL16 in Crohnʼs disease and models of intestinal inflammation
- (2010) Julia Diegelmann et al. INFLAMMATORY BOWEL DISEASES
- Chemokine CXCL16 Regulates Neutrophil and Macrophage Infiltration into Injured Muscle, Promoting Muscle Regeneration
- (2009) Liping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Chemokine C–X–C motif receptor 6 contributes to cell migration during hypoxia
- (2009) Sensen Lin et al. CANCER LETTERS
- Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis
- (2008) S.-Y. Sung et al. CANCER RESEARCH
- CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
- (2008) J. Wang et al. CANCER RESEARCH
- The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6
- (2008) Kirsten Hattermann et al. MOLECULAR AND CELLULAR NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started